Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene inhibits protein synthesis of rat ventricular cardiomyocytes

Citation
Y. Maeda et al., Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene inhibits protein synthesis of rat ventricular cardiomyocytes, CARDIO DRUG, 15(1), 2001, pp. 19-24
Citations number
33
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CARDIOVASCULAR DRUGS AND THERAPY
ISSN journal
09203206 → ACNP
Volume
15
Issue
1
Year of publication
2001
Pages
19 - 24
Database
ISI
SICI code
0920-3206(2001)15:1<19:AVTOEN>2.0.ZU;2-T
Abstract
We investigated whether nitric oxide (NO) synthase gene transfer could atte nuate growth of cultured cardiac myocytes. First, we investigated the effec ts of exogenous NO and cGMP analog on protein synthesis of cultured neonata l rat cardiac myocytes. The NO donor 3-morpholino-sydnonimine-hydrochloride (SIN-1) and 8-bromo-cGMP caused concentration-dependent decreases in pheny lephrine-stimulated incorporation of H-3-leucine into cardiac myocytes. We then transferred endothelial constitutive NO synthase (ecNOS) gene into cul tured neonatal rat cardiac myocytes using adeno-associated virus (AAV) vect ors. ecNOS gene transfer into cardiac myocytes induced 140 kD ecNOS protein expression and significantly increased cGMP contents of myocytes compared with control cells. ecNOS gene transfer inhibited H-3-leucine incorporation into cardiac myocytes in response to phenylephrine, which was significantl y recovered in the presence of the NOS inhibitor N-G-monomethyl-L-arginine acetate. These results indicate that endogenously generated NO by ecNOS gen e transfer using AAV vectors inhibits the alpha -adrenergic agonist-induced cardiac protein synthesis at least partially via cGMP production.